The Utility of Positron Emission Tomography Scanning in Parkinson’s Disease
Dr. Jason Seewoodhary1
,Dr. Stephen Wong MD FRCP (UK)2
Journal Title:American Research Journal of Medicine and surgery
Abstract
Positron Emission Tomography (PET) can visualise progression of Parkinsonian pathophysiology from
early- through to end-stage disease generating objective quantitative longitudinal data, which enables assessing
responses to treatment. The utility of PET scanning in the management of Parkinson's Disease is further
exemplified by: refining the differential diagnosis of Parkinson's Disease as a distinct neurochemical entity;
monitoring the efficacy of foetal nigral tissue transplantation; assessing the effects of surgical interventions such
as deep brain stimulation; and guiding clinical management by studying the effects of drug-induced adverse
effects. This concise review critically considers the role of PET scanning in the management of Parkinson’s
Disease.
Download